Capital Bank & Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Capital Bank & Trust’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,400	Closed	-$207K	–	390
2020 Q4	$207K	Hold	8,400	–	–	﹤0.01%	344
2020 Q3	$348K	Hold	8,400	–	–	﹤0.01%	252
2020 Q2	$402K	Hold	8,400	–	–	0.01%	240
2020 Q1	$529K	Hold	8,400	–	–	0.01%	208
2019 Q4	$1.04M	Hold	8,400	–	–	0.01%	192
2019 Q3	$557K	Hold	8,400	–	–	0.01%	209
2019 Q2	$668K	Buy	+8,400	New	+$752K	0.01%	208

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Capital Bank & Trust's ICPT Position: Q1 2021 in Review

Capital Bank & Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 8,400 shares — an estimated $207K sold.

Capital Bank & Trust first reported a position in ICPT in Q2 2019 and held it in 7 quarters. The position peaked at $1.04M in Q4 2019. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

Capital Bank & Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Capital Bank & Trust sold 8,400 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $207K.
Capital Bank & Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2019 and held it in 7 quarters.
Capital Bank & Trust's Intercept Pharmaceuticals, Inc. position peaked at $1.04M in Q4 2019.
151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Capital Bank & Trust's 13F filing for Q1 2021, filed 14 May 2021.